Medical Device Maker Venus Medtech Pumps Up Investors With Prospect of 2021 Profits
Company funds expansion through $400 million share sale as it targets U.S. and EU with growing pipeline of heart valve-replacement products Major Takeaways Venus Medtech’s recent $400 million equity fundraising…
RELATED ARTICLES
-
Venus Medtech still seeking cure for governance problems
2500.HK
-
FAST NEWS: Venus Medtech’s loss narrows on surging overseas sales
2500.HK
-
FAST NEWS: Venus Medtech lends to directors without required disclosure
2500.HK
-
FAST NEWS: PW Medtech’s profit jumps on post-Covid rebound
1358.HK
-
Country Garden deconstructed by slumping sales, heavy debt
2007.HK 6098.HK
-
Aoyuan gets relief from debt restructure, as its fate stays tied to property market
3883.HK
-
Shaky Vanke finds stabilizing friend in Shenzhen government
2202.HK 000002.SHE
Discover hidden China stock gems in our weekly newsletter